...
首页> 外文期刊>Pediatric Hematology and Oncology >CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PRESENTING WITH SEVERE OSTEOLYSIS: A Model to Study Leukemia-Bone Interactions and Potential Targeted Therapeutics
【24h】

CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PRESENTING WITH SEVERE OSTEOLYSIS: A Model to Study Leukemia-Bone Interactions and Potential Targeted Therapeutics

机译:伴有严重骨溶解的儿童急性淋巴细胞性白血病(全部):研究白血病-骨相互作用和潜在靶向治疗药物的模型

获取原文
获取原文并翻译 | 示例
           

摘要

Interference with the molecular mechanisms that generate tumor supportive niches in the bone microenvironment is a rational approach to inhibit the growth of hematobgical malignancies. However, the advancement of knowledge in this area has been slowed down by the lack of in vitro models to facilitate the screening of potential candidate agents. The rare cases of acute lymphoblastic leukemia (ALL) in children presenting with extensive bone involvement may represent an exaggerated form of some aspects of the normal tumor-bone interactions. Thus, these cases can provide insight into processes that are otherwise challenging to uncover. The authors describe the case of a 6-year-old child, who presented with severe osteopenia that resolved, at the time of leukemic remission. Compared, to control sera, serum taken at disease presentation contained increased levels of a group of osteolytic cytokines and was effective in activating pr-eosteodast cells in culture. Based on these findings, the authors describe an experimental model to identify agents that would, interfere with leukemia mediated osteolytic process.
机译:干扰在骨骼微环境中产生肿瘤支持位的分子机制是抑制血液恶性肿瘤生长的合理方法。然而,由于缺乏用于筛选潜在候选药物的体外模型,该领域知识的发展已减慢。小儿出现严重骨骼受累的儿童急性淋巴细胞白血病(ALL)可能代表正常肿瘤-骨骼相互作用某些方面的夸大形式。因此,这些案例可以提供对难以发现的过程的洞察力。作者描述了一个6岁儿童的案例,该儿童在白血病缓解时表现出严重的骨质疏松症,现已消退。相比于对照血清,在疾病表现时采集的血清包含增加的一组溶骨细胞因子水平,并且在激活培养物中的原骨钙蛋白细胞方面是有效的。基于这些发现,作者描述了一种实验模型,以识别会干扰白血病介导的溶骨过程的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号